Traci C. Green, Ph.D. - Publications

Affiliations: 
2009 Yale University, New Haven, CT 
Area:
Epidemiology, Public Health

137 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Jarrett JB, Bratberg J, Burns AL, Cochran G, DiPaula BA, Legreid Dopp A, Elmes A, Green TC, Hill LG, Homsted F, Hsia SL, Matthews ML, Ghitza UE, Wu LT, Bart G. Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy. Substance Abuse. 44: 264-276. PMID 37902032 DOI: 10.1177/08897077231203849  0.364
2023 Hughto JMW, Tapper A, Rapisarda SS, Stopka TJ, Palacios WR, Case P, Silcox J, Moyo P, Green TC. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs. Substance Abuse Treatment, Prevention, and Policy. 18: 30. PMID 37217975 DOI: 10.1186/s13011-023-00538-x  0.377
2023 Xuan Z, Yan S, Formica SW, Green TC, Beletsky L, Rosenbloom D, Bagley SM, Kimmel SD, Carroll JJ, Lambert AM, Walley AY. Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities. Jama Psychiatry. PMID 36920385 DOI: 10.1001/jamapsychiatry.2023.0109  0.368
2022 Bohler RM, Freeman PR, Villani J, Hunt T, Linas BS, Walley AY, Green TC, Lofwall MR, Bridden C, Frazier LA, Fanucchi LC, Talbert JC, Chandler R. The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses. Drug and Alcohol Dependence Reports. 6. PMID 36643788 DOI: 10.1016/j.dadr.2022.100126  0.326
2022 Floyd AS, Silcox J, Cousin E, Irwin AN, Gray M, Bolivar D, Bratberg J, Arnold J, Al-Jammali Z, Hansen RN, Hartung DM, Green TC. Readiness of community pharmacies to implement an opioid safety intervention. Journal of the American Pharmacists Association : Japha. PMID 36496310 DOI: 10.1016/j.japh.2022.10.031  0.355
2022 Morgan JR, Freibott CE, Jalali A, Jeng PJ, Walley AY, Chatterjee A, Green TC, Nolan ML, Linas BP, Marshall BDL, Murphy SM. The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City. Drug and Alcohol Dependence Reports. 4. PMID 36337350 DOI: 10.1016/j.dadr.2022.100083  0.324
2022 Hill LG, Light AE, Green TC, Burns AL, Sanaty Zadeh P, Freeman PR. Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists. Journal of the American Pharmacists Association : Japha. PMID 36202711 DOI: 10.1016/j.japh.2022.08.017  0.37
2022 McMahan VM, Arenander J, Matheson T, Lambert AM, Brennan S, Green TC, Walley AY, Coffin PO. "There's No Heroin Around Anymore. It's All Fentanyl." Adaptation of an Opioid Overdose Prevention Counseling Approach to Address Fentanyl Overdose: Formative Study. Jmir Formative Research. 6: e37483. PMID 36069781 DOI: 10.2196/37483  0.396
2022 Pollini RA, Slocum S, Ozga JE, Joyce R, Xuan Z, Green TC, Walley AY. Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program. Journal of the American Pharmacists Association : Japha. PMID 35450833 DOI: 10.1016/j.japh.2022.03.015  0.318
2022 Hughto JMW, Moyo P, Green TC. Medicaid Prescription Cap Policies: Another Structural Barrier to Medication for Opioid Use Disorder. Journal of Addiction Medicine. PMID 35245915 DOI: 10.1097/ADM.0000000000000980  0.4
2022 Green TC, Bratberg J, Irwin AN, Boggis J, Gray M, Leichtling G, Bolivar D, Floyd A, Al-Jammali Z, Arnold J, Hansen R, Hartung D. Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies. Substance Abuse. 43: 901-905. PMID 35213293 DOI: 10.1080/08897077.2021.2010162  0.396
2022 Irvine MA, Oller D, Boggis J, Bishop B, Coombs D, Wheeler E, Doe-Simkins M, Walley AY, Marshall BDL, Bratberg J, Green TC. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. The Lancet. Public Health. PMID 35151372 DOI: 10.1016/S2468-2667(21)00304-2  0.376
2021 Chatterjee A, Yan S, Xuan Z, Waye KM, Lambert AM, Green TC, Stopka TJ, Pollini RA, Morgan JR, Walley AY. Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts. Drug and Alcohol Dependence. 230: 109190. PMID 34864356 DOI: 10.1016/j.drugalcdep.2021.109190  0.335
2021 Zang X, Macmadu A, Krieger MS, Behrends CN, Green TC, Morgan JR, Murphy SM, Nolen S, Walley AY, Schackman BR, Marshall BD. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. The International Journal On Drug Policy. 98: 103435. PMID 34482264 DOI: 10.1016/j.drugpo.2021.103435  0.359
2021 Shrestha S, Stopka TJ, Hughto JMW, Case P, Palacios WR, Reilly B, Green TC. Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017-2019. Harm Reduction Journal. 18: 93. PMID 34461922 DOI: 10.1186/s12954-021-00538-9  0.334
2021 Hughto JMW, Gordon L, Stopka TJ, Case P, Palacios WR, Tapper A, Green TC. Understanding opioid overdose risk and response preparedness among people who use cocaine and other drugs: Mixed-methods findings from a large, multi-city study. Substance Abuse. 1-14. PMID 34228944 DOI: 10.1080/08897077.2021.1946893  0.342
2021 Gandhi P, Rouhani S, Park JN, Urquhart GJ, Allen ST, Morales KB, Green TC, Sherman SG. Alternative use of buprenorphine among people who use opioids in three U.S. Cities. Substance Abuse. 1-7. PMID 34214403 DOI: 10.1080/08897077.2021.1942395  0.309
2021 Kaplowitz E, Truong AQ, Macmadu A, Peterson M, Brinkley-Rubinstein L, Potter N, Green TC, Clarke JG, Rich JD. Fentanyl-related overdose during incarceration: a comprehensive review. Health & Justice. 9: 13. PMID 34013442 DOI: 10.1186/s40352-021-00138-6  0.326
2021 Green TC, Kaplowitz E, Langdon K, Hughto JMW, Goedel WC, Czynski AJ, Fraser G, Rich J. COBRE on Opioid and Overdose: A Collaborative Research-Based Center Addressing the Crises in Rhode Island and Beyond. Rhode Island Medical Journal (2013). 104: 22-26. PMID 33789404  0.366
2020 Gaur DS, Jacka BP, Green TC, Samuels EA, Hadland SE, Krieger MS, Yedinak JL, Marshall BDL. US drug overdose mortality: 2009-2018 increases affect young people who use drugs. The International Journal On Drug Policy. 85: 102906. PMID 33070095 DOI: 10.1016/j.drugpo.2020.102906  0.339
2020 Carroll JJ, Mital S, Wolff J, Noonan RK, Martinez P, Podolsky MC, Killorin JC, Green TC. Knowledge, preparedness, and compassion fatigue among law enforcement officers who respond to opioid overdose. Drug and Alcohol Dependence. 217: 108257. PMID 32947173 DOI: 10.1016/J.Drugalcdep.2020.108257  0.459
2020 Macmadu A, Adams JW, Bessey SE, Brinkley-Rubinstein L, Martin RA, Clarke JG, Green TC, Rich JD, Marshall BDL. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study. The International Journal On Drug Policy. 102841. PMID 32712165 DOI: 10.1016/J.Drugpo.2020.102841  0.449
2020 Pollini RA, Joyce R, Ozga-Hess JE, Xuan Z, Green TC, Walley AY. Assessing pharmacy-based naloxone access using an innovative purchase trial methodology. Journal of the American Pharmacists Association : Japha. PMID 32651116 DOI: 10.1016/j.japh.2020.05.016  0.357
2020 Walley AY, Bernson D, Larochelle MR, Green TC, Young L, Land T. Response to Letter to the Editor: The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015. Public Health Reports (Washington, D.C. : 1974). 33354920935076. PMID 32614735 DOI: 10.1177/0033354920935076  0.353
2020 Stone AC, Carroll JJ, Rich JD, Green TC. One year of methadone maintenance treatment in a fentanyl endemic area: Safety, repeated exposure, retention, and remission. Journal of Substance Abuse Treatment. 115: 108031. PMID 32600619 DOI: 10.1016/J.Jsat.2020.108031  0.385
2020 Wakeman SE, Green TC, Rich J. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nature Medicine. 26: 819-820. PMID 32555514 DOI: 10.1038/S41591-020-0898-0  0.403
2020 Green TC, Donovan E, Klug B, Case P, Baird J, Burstein D, Tapper A, Walley AY, Bratberg J. Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches. Journal of the American Pharmacists Association : Japha. PMID 32334964 DOI: 10.1016/J.Japh.2020.03.005  0.495
2020 Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment. Substance Abuse. 41: 147-149. PMID 32314951 DOI: 10.1080/08897077.2020.1752351  0.35
2020 Green TC, Davis C, Xuan Z, Walley AY, Bratberg J. Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018. American Journal of Public Health. e1-e7. PMID 32298179 DOI: 10.2105/Ajph.2020.305620  0.442
2020 Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. Trends in opioid initiation among people who use opioids in three US cities. Drug and Alcohol Review. PMID 32249463 DOI: 10.1111/Dar.13060  0.518
2020 Green TC, Soipe A, Baloy B, Burstein D, Xuan Z, Tapper A, Walley AY, Case P, Bratberg J, Baird J. Pharmacy on-site overdose protocols and prevention of overdose. Substance Abuse. 1-5. PMID 32186478 DOI: 10.1080/08897077.2020.1736236  0.437
2020 Carroll JJ, Rich JD, Green TC. The protective effect of trusted dealers against opioid overdose in the U.S. The International Journal On Drug Policy. 78: 102695. PMID 32143185 DOI: 10.1016/J.Drugpo.2020.102695  0.445
2020 Macmadu A, Goedel WC, Adams JW, Brinkley-Rubinstein L, Green TC, Clarke JG, Martin RA, Rich JD, Marshall BDL. Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails. Drug and Alcohol Dependence. 208: 107858. PMID 32050112 DOI: 10.1016/J.Drugalcdep.2020.107858  0.415
2020 Donovan E, Bratberg J, Baird J, Burstein D, Case P, Walley AY, Green TC. Pharmacy leaders' beliefs about how pharmacies can support a sustainable approach to providing naloxone to the community. Research in Social & Administrative Pharmacy : Rsap. PMID 31983625 DOI: 10.1016/J.Sapharm.2020.01.006  0.42
2020 Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, Clarke W, Sherman SG. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. The International Journal On Drug Policy. 77: 102661. PMID 31951925 DOI: 10.1016/J.Drugpo.2020.102661  0.349
2019 Green TC, Bratberg J, Baird J, Burstein D, Lenz K, Case P, Walley AY, Xuan Z. Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy. The International Journal On Drug Policy. 102602. PMID 31740174 DOI: 10.1016/J.Drugpo.2019.11.010  0.409
2019 Hackman HH, Koziol JA, McCormick M, McDonald JV, Green TC. Multidisciplinary Team Reviews of Drug Overdose Deaths and the Use of Minigrants to Advance Recommendations: A Statewide Pilot in Rhode Island. Journal of Public Health Management and Practice : Jphmp. PMID 31688739 DOI: 10.1097/Phh.0000000000001081  0.45
2019 Brinkley-Rubinstein L, Peterson M, Clarke J, Macmadu A, Truong A, Pognon K, Parker M, Marshall B, Green T, Martin R, Stein L, Rich JD. The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting. Drug and Alcohol Dependence. 205: 107514. PMID 31614328 DOI: 10.1016/J.Drugalcdep.2019.06.016  0.409
2019 Kurian S, Baloy B, Baird J, Burstein D, Xuan Z, Bratberg J, Tapper A, Walley A, Green T. Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians. Journal of the American Pharmacists Association : Japha. PMID 31582224 DOI: 10.1016/J.Japh.2019.08.009  0.313
2019 Walley AY, Bernson D, Larochelle MR, Green TC, Young L, Land T. The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015. Public Health Reports (Washington, D.C. : 1974). 33354919878429. PMID 31577519 DOI: 10.1177/0033354919878429  0.473
2019 Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities. Drug and Alcohol Dependence. 204: 107547. PMID 31536877 DOI: 10.1016/J.Drugalcdep.2019.107547  0.447
2019 Baird J, Faul M, Green TC, Howland J, Adams CA, Hodne MJ, Bohlen N, Mello MJ. Evaluation of a Safer Opioid Prescribing Protocol (SOPP) for Patients Being Discharged From a Trauma Service. Journal of Trauma Nursing : the Official Journal of the Society of Trauma Nurses. 26: 113-120. PMID 31483766 DOI: 10.1097/Jtn.0000000000000435  0.474
2019 Bouvier BA, Kinnard EN, Yedinak JL, Li Y, Elston B, Green TC, Hadland SE, Marshall BDL. Prevalence and Correlates of Depressive Symptomology among Young Adults Who Use Prescription Opioids Non-medically. Journal of Psychoactive Drugs. 1-12. PMID 31411548 DOI: 10.1080/02791072.2019.1654151  0.317
2019 Rouhani S, Park JN, Morales KB, Green TC, Sherman SG. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Harm Reduction Journal. 16: 39. PMID 31234942 DOI: 10.1186/S12954-019-0311-9  0.448
2019 Goldman JE, Krieger MS, Buxton JA, Lysyshyn M, Sherman SG, Green TC, Bernstein E, Hadland SE, Marshall BDL. Suspected involvement of fentanyl in prior overdoses and engagement in harm reduction practices among young adults who use drugs. Substance Abuse. 1-8. PMID 31206354 DOI: 10.1080/08897077.2019.1616245  0.458
2019 Goedel WC, Marshall BDL, Spangler KR, Alexander-Scott N, Green TC, Wellenius GA, Weinberger KR. Increased risk of opioid overdose death following cold weather: A case-crossover study. Epidemiology (Cambridge, Mass.). PMID 31205291 DOI: 10.1097/Ede.0000000000001041  0.463
2019 Park JN, Sherman SG, Rouhani S, Morales KB, McKenzie M, Allen ST, Marshall BDL, Green TC. Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston. Journal of Urban Health : Bulletin of the New York Academy of Medicine. PMID 31168735 DOI: 10.1007/S11524-019-00365-1  0.485
2019 Banerjee G, Edelman EJ, Barry DT, Crystal S, Gordon KS, Gordon AJ, Gaither JR, Green TC, Kerns RD, Manhapra A, Moore BA, Fiellin DA, Marshall BD. High-dose prescribed opioids are associated with increased risk of heroin use among US military veterans. Pain. PMID 31145217 DOI: 10.1097/J.Pain.0000000000001606  0.471
2019 Peterson M, Rich J, Macmadu A, Truong AQ, Green TC, Beletsky L, Pognon K, Brinkley-Rubinstein L. "One guy goes to jail, two people are ready to take his spot": Perspectives on drug-induced homicide laws among incarcerated individuals. The International Journal On Drug Policy. 70: 47-53. PMID 31082662 DOI: 10.1016/J.Drugpo.2019.05.001  0.391
2019 Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. The International Journal On Drug Policy. 68: 46-53. PMID 30991301 DOI: 10.1016/J.Drugpo.2019.03.003  0.437
2019 Donovan E, Case P, Bratberg JP, Baird J, Burstein D, Walley AY, Green TC. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose. Journal of Urban Health : Bulletin of the New York Academy of Medicine. PMID 30747371 DOI: 10.1007/S11524-019-00349-1  0.518
2018 Glick JL, Christensen T, Nyeong Park J, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study. Drug and Alcohol Dependence. 194: 527-532. PMID 30551090 DOI: 10.1016/J.Drugalcdep.2018.10.017  0.46
2018 Nielsen S, Kowalski M, Wood P, Larney S, Bruno R, Shanahan M, Lenton S, Dietze P, Green T, Murnion B, Ritter A. Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol. Research in Social & Administrative Pharmacy : Rsap. PMID 30396825 DOI: 10.1016/J.Sapharm.2018.10.024  0.474
2018 Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, Rich JD, Hadland SE, Green TC, Marshall BDL. Use of rapid fentanyl test strips among young adults who use drugs. The International Journal On Drug Policy. PMID 30344005 DOI: 10.1016/J.Drugpo.2018.09.009  0.366
2018 Stone AC, Carroll JJ, Rich JD, Green TC. Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months. Drug and Alcohol Dependence. 192: 94-97. PMID 30243145 DOI: 10.1016/J.Drugalcdep.2018.07.019  0.384
2018 Carroll JJ, Rich JD, Green TC. The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible. Journal of Addiction Medicine. PMID 30095563 DOI: 10.1097/Adm.0000000000000436  0.489
2018 Davis CS, Green TC, Hernandez-Delgado H, Lieberman AJ. Status of US State Laws Mandating Timely Reporting of Nonfatal Overdose. American Journal of Public Health. 108: 1159-1161. PMID 30088991 DOI: 10.2105/Ajph.2018.304589  0.308
2018 Green TC, Rich JD, Sharfstein J. Commentary on 'Revisiting the 'paradigm shift' in opioid use: Developments and implications 10 years later'. Drug and Alcohol Review. PMID 29479758 DOI: 10.1111/Dar.12684  0.434
2018 Brinkley-Rubinstein L, Macmadu A, Marshall BDL, Heise A, Ranapurwala SI, Rich JD, Green TC. Risk of fentanyl-involved overdose among those with past year incarceration: Findings from a recent outbreak in 2014 and 2015. Drug and Alcohol Dependence. 185: 189-191. PMID 29459328 DOI: 10.1016/J.Drugalcdep.2017.12.014  0.384
2018 Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BDL, Alexander-Scott N, Boss R, Rich JD. Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System. Jama Psychiatry. PMID 29450443 DOI: 10.1001/Jamapsychiatry.2017.4614  0.301
2018 Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, Green TC, Hadland SE, Marshall BDL. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduction Journal. 15: 7. PMID 29422052 DOI: 10.1186/S12954-018-0213-2  0.421
2018 Carroll JJ, Rich JD, Green TC. Reducing Collateral Damage in Responses to the Opioid Crisis. American Journal of Public Health. 108: 349-350. PMID 29412724 DOI: 10.2105/Ajph.2017.304270  0.498
2018 Marshall BDL, Green TC, Elston B, Yedinak JL, Hadland SE, Clark MA. The Effectiveness of Internet- and Field-Based Methods to Recruit Young Adults Who Use Prescription Opioids Nonmedically. Substance Use & Misuse. 1-12. PMID 29364768 DOI: 10.1080/10826084.2018.1425725  0.441
2017 Bouvier BA, Waye KM, Elston B, Hadland SE, Green TC, Marshall BDL. Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically. Drug and Alcohol Dependence. 183: 73-77. PMID 29241103 DOI: 10.1016/J.Drugalcdep.2017.10.023  0.481
2017 Soipe AI, Taylor LE, Abioye AI, Green TC, Hadland SE, Marshall BDL. Prevalence of Hepatitis C Screening, Testing, and Care Experience Among Young Adults Who Use Prescription Opioids Nonmedically. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 29102250 DOI: 10.1016/J.Jadohealth.2017.07.018  0.344
2017 Marshall BDL, Yedinak JL, Goyer J, Green TC, Koziol JA, Alexander-Scott N. Development of a Statewide, Publicly Accessible Drug Overdose Surveillance and Information System. American Journal of Public Health. e1-e4. PMID 28933938 DOI: 10.2105/Ajph.2017.304007  0.319
2017 Liebling EJ, Green TC, Hadland SE, Marshall BDL. Injection drug use and overdose among young adults who use prescription opioids non-medically. Addictive Behaviors. 76: 20-26. PMID 28735037 DOI: 10.1016/J.Addbeh.2017.07.017  0.494
2017 Davis C, Green T, Beletsky L. Action, Not Rhetoric, Needed to Reverse the Opioid Overdose Epidemic. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 45: 20-23. PMID 28661292 DOI: 10.1177/1073110517703310  0.405
2017 Baird J, Faul M, Green TC, Howland J, Adams CA, George A, Mello MJ. A retrospective review of unintentional opioid overdose risk and mitigating factors among acutely injured trauma patients. Drug and Alcohol Dependence. 178: 130-135. PMID 28647680 DOI: 10.1016/J.Drugalcdep.2017.04.030  0.462
2017 Marshall BDL, Krieger MS, Yedinak JL, Ogera P, Banerjee P, Alexander-Scott NE, Rich JD, Green TC. Epidemiology of fentanyl-involved drug overdose deaths: A geospatial retrospective study in Rhode Island, USA. The International Journal On Drug Policy. PMID 28601512 DOI: 10.1016/J.Drugpo.2017.05.029  0.379
2017 Carroll JJ, Marshall BDL, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. The International Journal On Drug Policy. PMID 28578864 DOI: 10.1016/J.Drugpo.2017.05.023  0.467
2017 Horton M, McDonald R, Green TC, Nielsen S, Strang J, Degenhardt L, Larney S. A mapping review of take-home naloxone for people released from correctional settings. The International Journal On Drug Policy. 46: 7-16. PMID 28575724 DOI: 10.1016/J.Drugpo.2017.05.015  0.343
2017 Evans TI, Liebling EJ, Green TC, Hadland SE, Clark MA, Marshall BDL. Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis. Journal of Addiction Medicine. PMID 28514234 DOI: 10.1097/Adm.0000000000000318  0.33
2017 Somerville NJ, O'Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, Ruiz S, Babakhanlou-Chase H, Chan M, Callis BP, Kuramoto-Crawford J, Nields HM, Walley AY. Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016. Mmwr. Morbidity and Mortality Weekly Report. 66: 382-386. PMID 28406883 DOI: 10.15585/Mmwr.Mm6614A2  0.514
2017 Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduction Journal. 14: 13. PMID 28219388 DOI: 10.1186/S12954-017-0139-0  0.458
2017 Green TC, Case P, Fiske H, Baird J, Cabral S, Burstein D, Schwartz V, Potter N, Walley AY, Bratberg J. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. Journal of the American Pharmacists Association : Japha. PMID 28214219 DOI: 10.1016/J.Japh.2017.01.013  0.488
2017 Stopka TJ, Donahue A, Hutcheson M, Green TC. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015. Journal of the American Pharmacists Association : Japha. PMID 28189540 DOI: 10.1016/J.Japh.2016.12.077  0.4
2017 Kobayashi L, Green TC, Bowman SE, Ray MC, McKenzie MS, Rich JD. Patient Simulation for Assessment of Layperson Management of Opioid Overdose With Intranasal Naloxone in a Recently Released Prisoner Cohort. Simulation in Healthcare : Journal of the Society For Simulation in Healthcare. 12: 22-27. PMID 28146450 DOI: 10.1097/Sih.0000000000000182  0.414
2017 Freeman PR, Goodin A, Troske S, Strahl A, Fallin A, Green TC. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing. Journal of the American Pharmacists Association : Japha. PMID 28139459 DOI: 10.1016/J.Japh.2016.12.064  0.47
2017 Macmadu A, Carroll JJ, Hadland SE, Green TC, Marshall BD. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addictive Behaviors. 68: 35-38. PMID 28088741 DOI: 10.1016/J.Addbeh.2017.01.014  0.46
2016 Yedinak JL, Kinnard EN, Hadland SE, Green TC, Clark MA, Marshall BD. Social context and perspectives of non-medical prescription opioid use among young adults in Rhode Island: A qualitative study. The American Journal On Addictions. 25: 659-665. PMID 28051839 DOI: 10.1111/Ajad.12466  0.451
2016 Liebling EJ, Yedinak JL, Green TC, Hadland SE, Clark MA, Marshall BD. Access to substance use treatment among young adults who use prescription opioids non-medically. Substance Abuse Treatment, Prevention, and Policy. 11: 38. PMID 27894311 DOI: 10.1186/S13011-016-0082-1  0.475
2016 Green TC, Gilbert M. Counterfeit Medications and Fentanyl. Jama Internal Medicine. PMID 27533891 DOI: 10.1001/Jamainternmed.2016.4310  0.43
2016 Evans TI, Hadland SE, Clark MA, Green TC, Marshall BD. Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm Reduction Journal. 13: 24. PMID 27455957 DOI: 10.1186/S12954-016-0113-2  0.415
2016 Walley AY, Green TC. Mainstreaming Naloxone Through Coprescription to Patients Receiving Long-Term Opioid Therapy for Chronic Pain. Annals of Internal Medicine. PMID 27367047 DOI: 10.7326/M16-1348  0.401
2016 Lim JK, Bratberg JP, Davis CS, Green TC, Walley AY. Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists. Journal of Addiction Medicine. PMID 27261669 DOI: 10.1097/Adm.0000000000000223  0.463
2016 Saucier CD, Zaller N, Macmadu A, Green TC. An Initial evaluation of law enforcement overdose training in Rhode Island. Drug and Alcohol Dependence. PMID 27020323 DOI: 10.1016/J.Drugalcdep.2016.03.011  0.324
2016 Marshall BD, Green TC, Yedinak JL, Hadland SE. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. The International Journal On Drug Policy. PMID 26919826 DOI: 10.1016/J.Drugpo.2016.01.022  0.497
2016 Green TC, Doe-Simkinsc M. Opioid overdose and naloxone: The antidote to an epidemic? Drug and Alcohol Dependence. 163: 265-271. DOI: 10.1016/j.drugalcdep.2016.03.024  0.351
2015 Weiner SG, Horton LC, Green TC, Butler SF. A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department. Drug and Alcohol Dependence. PMID 26743334 DOI: 10.1016/J.Drugalcdep.2015.12.007  0.388
2015 Davis CS, Green TC, Zaller ND. Addressing the overdose epidemic requires timely access to data to guide interventions. Drug and Alcohol Review. PMID 26382016 DOI: 10.1111/Dar.12321  0.37
2015 Green TC, Dauria EF, Bratberg J, Davis CS, Walley AY. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm Reduction Journal. 12: 25. PMID 26245865 DOI: 10.1186/S12954-015-0058-X  0.526
2015 Green TC, Bowman S, Davis C, Los C, McHugh K, Friedmann PD. Discrepancies in addressing overdose prevention through prescription monitoring programs. Drug and Alcohol Dependence. PMID 26048640 DOI: 10.1016/J.Drugalcdep.2015.05.009  0.449
2015 Weiner SG, Horton LC, Green TC, Butler SF. Feasibility of tablet computer screening for opioid abuse in the emergency department. The Western Journal of Emergency Medicine. 16: 18-23. PMID 25671003 DOI: 10.5811/Westjem.2014.11.23316  0.416
2015 Green TC, Griffel C, Dailey T, Garg P, Thorley E, Kaczmarsky C, Cassidy T, Butler SF. How did you know you got the right pill? Prescription opioid identification and measurement error in the abuse deterrent formulation era Addiction Science & Clinical Practice. 10. DOI: 10.1186/1940-0640-10-S1-A16  0.416
2015 Green TC, Bowman SE, Ray M, McKenzie M, Lord SE, Rich JD. Development of an incarceration-specific overdose prevention video: Staying Alive on the Outside Health Education Journal. 74: 627-637. DOI: 10.1177/0017896914550321  0.411
2015 Weiner SG, Horton LC, Green TC, Butler SF. A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department Drug and Alcohol Dependence. DOI: 10.1016/j.drugalcdep.2015.12.007  0.344
2015 Green T, Doe-Simkins M, Barratt M, Cassidy T, Butler SF. Polysubstance combinations involving prescription opioids and rationales for combining among people who use internet drug discussion forums Drug and Alcohol Dependence. 156: e83. DOI: 10.1016/J.Drugalcdep.2015.07.1143  0.416
2015 Cassidy T, Green T, Garg P, Butler SF. Up in smoke? Marijuana initiation and prevalence trends in Colorado: 2008 to 2014 Drug and Alcohol Dependence. 156: e39. DOI: 10.1016/J.Drugalcdep.2015.07.1023  0.393
2015 Green T, Bowman S, Los C, McHugh K, Friedmann P. Strategies to reduce prescription opioid abuse in the United States: How have they influenced the epidemic? Drug and Alcohol Dependence. 146: e129-e130. DOI: 10.1016/J.Drugalcdep.2014.09.270  0.445
2014 Choo EK, Douriez C, Green T. Gender and prescription opioid misuse in the emergency department. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 21: 1493-8. PMID 25491712 DOI: 10.1111/Acem.12547  0.455
2014 Yokell MA, Delgado MK, Zaller ND, Wang NE, McGowan SK, Green TC. Presentation of prescription and nonprescription opioid overdoses to US emergency departments. Jama Internal Medicine. 174: 2034-7. PMID 25347221 DOI: 10.1001/Jamainternmed.2014.5413  0.457
2014 Green TC, Bratberg J, Dauria EF, Rich JD. Responding to opioid overdose in Rhode Island: where the medical community has gone and where we need to go. Rhode Island Medical Journal (2013). 97: 29-33. PMID 25271657  0.398
2014 Green TC, Ray M, Bowman SE, McKenzie M, Rich JD. Two cases of intranasal naloxone self-administration in opioid overdose. Substance Abuse. 35: 129-32. PMID 24821348 DOI: 10.1080/08897077.2013.825691  0.45
2014 Wakeman SE, Green TC, Rich JD. From documenting death to comprehensive care: Applying lessons from the HIV/AIDS epidemic to addiction. The American Journal of Medicine. 127: 465-6. PMID 24412918 DOI: 10.1016/J.Amjmed.2013.12.018  0.403
2013 Green TC, Zaller N, Palacios WR, Bowman SE, Ray M, Heimer R, Case P. Law enforcement attitudes toward overdose prevention and response. Drug and Alcohol Dependence. 133: 677-84. PMID 24051061 DOI: 10.1016/J.Drugalcdep.2013.08.018  0.642
2013 Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Substance Use & Misuse. 48: 590-9. PMID 23750660 DOI: 10.3109/10826084.2013.793355  0.41
2013 Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change pharmacy practice? Journal of the American Pharmacists Association : Japha. 53: 273-81. PMID 23699676 DOI: 10.1331/Japha.2013.12094  0.413
2013 Green TC, Bowman SE, Zaller ND, Ray M, Case P, Heimer R. Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders. Substance Use & Misuse. 48: 558-67. PMID 23647168 DOI: 10.3109/10826084.2013.787099  0.585
2013 Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. Initiation of buprenorphine during incarceration and retention in treatment upon release. Journal of Substance Abuse Treatment. 45: 222-6. PMID 23541303 DOI: 10.1016/J.Jsat.2013.02.005  0.327
2013 Green TC, Bowman SE, Ray M, Zaller N, Heimer R, Case P. Collaboration or coercion? Partnering to divert prescription opioid medications. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 90: 758-67. PMID 23371052 DOI: 10.1007/S11524-012-9784-5  0.647
2013 Green T, Bowman S, Ray M, Kobayashi L, McKenzie M, Rich J. Board 339 - Research Abstract Patient Simulation for Assessment and Reinforcement of Layperson Management of Opioid Overdose with Intranasal Naloxone in a Recently Released Prison Inmate Cohort (Submission #66) Simulation in Healthcare: the Journal of the Society For Simulation in Healthcare. 8: 538. DOI: 10.1097/01.Sih.0000441591.74717.45  0.384
2012 Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change medical practice? Pain Medicine (Malden, Mass.). 13: 1314-23. PMID 22845339 DOI: 10.1111/J.1526-4637.2012.01452.X  0.399
2012 Yokell MA, Zaller ND, Green TC, McKenzie M, Rich JD. Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose. Journal of Opioid Management. 8: 63-6. PMID 22479887 DOI: 10.5055/jom.2012.0098  0.411
2012 Green TC, Martin EG, Bowman SE, Mann MR, Beletsky L. Life after the ban: an assessment of US syringe exchange programs' attitudes about and early experiences with federal funding. American Journal of Public Health. 102: e9-16. PMID 22420810 DOI: 10.2105/Ajph.2011.300595  0.31
2012 Yokell MA, Green TC, Rich JD. Prescription drug monitoring programs. Jama. 307: 912; author reply 91. PMID 22396508 DOI: 10.1001/Jama.307.9.912-B  0.33
2012 McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD. A randomized trial of methadone initiation prior to release from incarceration. Substance Abuse. 33: 19-29. PMID 22263710 DOI: 10.1080/08897077.2011.609446  0.387
2012 Friedmann PD, Green TC, Taxman FS, Harrington M, Rhodes AG, Katz E, O'Connell D, Martin SS, Frisman LK, Litt M, Burdon W, Clarke JG, Fletcher BW. Collaborative behavioral management among parolees: drug use, crime and re-arrest in the Step'n Out randomized trial. Addiction (Abingdon, England). 107: 1099-108. PMID 22175445 DOI: 10.1111/J.1360-0443.2011.03769.X  0.316
2012 Green TC, McGowan SK, Yokell MA, Pouget ER, Rich JD. HIV infection and risk of overdose: a systematic review and meta-analysis. Aids (London, England). 26: 403-17. PMID 22112599 DOI: 10.1097/Qad.0B013E32834F19B6  0.36
2011 Green TC, Black R, Grimes Serrano JM, Budman SH, Butler SF. Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. Plos One. 6: e27244. PMID 22087270 DOI: 10.1371/Journal.Pone.0027244  0.472
2011 Yokell MA, Green TC, Bowman S, McKenzie M, Rich JD. Opioid overdose prevention and naloxone distribution in Rhode Island. Medicine and Health, Rhode Island. 94: 240-2. PMID 21913619  0.332
2011 Green TC, Zaller N, Rich J, Bowman S, Friedmann P. Revisiting Paulozzi et al.'s "Prescription drug monitoring programs and death rates from drug overdose". Pain Medicine (Malden, Mass.). 12: 982-5. PMID 21627763 DOI: 10.1111/J.1526-4637.2011.01136.X  0.395
2011 Yokell MA, Zaller ND, Green TC, Rich JD. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Current Drug Abuse Reviews. 4: 28-41. PMID 21466501 DOI: 10.2174/1874473711104010028  0.48
2011 Rich JD, Green TC, McKenzie MS. Opioids and deaths. The New England Journal of Medicine. 364: 686. PMID 21323559 DOI: 10.1056/Nejmc1014490  0.491
2011 Johnson JE, Friedmann PD, Green TC, Harrington M, Taxman FS. Gender and treatment response in substance use treatment-mandated parolees. Journal of Substance Abuse Treatment. 40: 313-21. PMID 21266302 DOI: 10.1016/J.Jsat.2010.11.013  0.307
2011 Green TC, Grau LE, Carver HW, Kinzly M, Heimer R. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. Drug and Alcohol Dependence. 115: 221-8. PMID 21131140 DOI: 10.1016/J.Drugalcdep.2010.11.007  0.641
2010 Green TC, Bluthenthal RN, Singer M, Beletsky L, Grau LE, Marshall P, Heimer R. Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies. Drug and Alcohol Dependence. 111: 74-81. PMID 20537814 DOI: 10.1016/J.Drugalcdep.2010.03.022  0.543
2010 Brownstein JS, Green TC, Cassidy TA, Butler SF. Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse. Pharmacoepidemiology and Drug Safety. 19: 627-37. PMID 20535759 DOI: 10.1002/Pds.1939  0.395
2010 Green TC, Kershaw T, Lin H, Heimer R, Goulet JL, Kraemer KL, Gordon AJ, Maisto SA, Day NL, Bryant K, Fiellin DA, Justice AC. Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. Drug and Alcohol Dependence. 110: 208-20. PMID 20395074 DOI: 10.1016/J.Drugalcdep.2010.02.020  0.532
2009 Grau LE, Green TC, Singer M, Bluthenthal RN, Marshall PA, Heimer R. Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users. Harm Reduction Journal. 6: 36. PMID 20003518 DOI: 10.1186/1477-7517-6-36  0.557
2009 Grau LE, Green TC, Torban M, Blinnikova K, Krupitsky E, Ilyuk R, Kozlov AP, Heimer R. Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, Russia. Harm Reduction Journal. 6: 17. PMID 19630963 DOI: 10.1186/1477-7517-6-17  0.633
2009 Green TC, Grimes Serrano JM, Licari A, Budman SH, Butler SF. Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug and Alcohol Dependence. 103: 65-73. PMID 19409735 DOI: 10.1016/J.Drugalcdep.2009.03.014  0.458
2009 Green TC, Grau LE, Blinnikova KN, Torban M, Krupitsky E, Ilyuk R, Kozlov A, Heimer R. Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. The International Journal On Drug Policy. 20: 270-6. PMID 18774283 DOI: 10.1016/J.Drugpo.2008.07.002  0.605
2008 Butler SF, Budman SH, Licari A, Cassidy TA, Lioy K, Dickinson J, Brownstein JS, Benneyan JC, Green TC, Katz N. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiology and Drug Safety. 17: 1142-54. PMID 18932173 DOI: 10.1002/Pds.1659  0.346
2008 Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction (Abingdon, England). 103: 979-89. PMID 18422830 DOI: 10.1111/J.1360-0443.2008.02182.X  0.593
2008 Butler S, Green T, Licari A, Budman S. (412) Women who abuse prescription opioids: Findings from the National Addictions Vigilance Intervention and Prevention Program The Journal of Pain. 9: 79. DOI: 10.1016/J.JPAIN.2008.01.013  0.306
2006 Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduction Journal. 3: 12. PMID 16545137 DOI: 10.1186/1477-7517-3-12  0.352
Show low-probability matches.